Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 vs S-1 plus irinotecan in advanced gastric cancer
jRCT1080220081Phase 3
- Sponsor
- Yakult Honsha
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in gastric cancer (GC) comparing S-1 monotherapy with S-1 plus irinotecan (2 arms).
02
Drugs
tegafuririnotecan
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT1080220081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080220081.